echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Cancers (Basel): Using machine learning models to study the related factors of thyroid-related adverse events in patients receiving PD-1 or PD-L1 inhibitors

    Cancers (Basel): Using machine learning models to study the related factors of thyroid-related adverse events in patients receiving PD-1 or PD-L1 inhibitors

    • Last Update: 2021-12-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Background and purpose: People are actively studying the molecular mechanisms of tumorigenesis and metastasis, especially T lymphocytes, especially the antigenic cytotoxicity, which has attracted more and more people's interest to develop immunotherapies for cancer treatment
    .


    Various negative regulators of T cell activation can be used as checkpoint molecules, such as cytotoxic T lymphocyte-associated protein 4 (CTLA-4) inhibitors, anti-programmed cell death 1 (PD-1) drugs, and anti-programmed cells Death Ligand 1 (PDL1) drug


    Various negative regulators of T cell activation can be used as checkpoint molecules, such as cytotoxic T lymphocyte-associated protein 4 (CTLA-4) inhibitors, anti-programmed cell death 1 (PD-1) drugs and anti-programmed cells The therapeutic target of


    Results: After adjusting for covariates, we found that smoking history and hypertension increased the risk of thyroid dysfunction by approximately 3.
    7 times and 4.
    1 times, respectively (95% confidence interval (ci) 1.
    338-10.
    496 and 1.
    478-11.
    332, p = 0.
    012 and 0.
    007)
    .


    In contrast, patients who took opioids had a risk of thyroid-related complications that were about 4.


    Table 1 Multivariate analysis to identify predictors of thyroid-related adverse events in patients treated with immune checkpoint inhibitors
    .

    Table 1 Multivariate analysis to identify predictors of thyroid-related adverse events in patients treated with immune checkpoint inhibitors
    .


    Table 2 AUC comparison of Logistic regression model, elastic network model, random forest model and support vector machine model
    .

    Table 2 AUC comparison of Logistic regression model, elastic network model, random forest model and support vector machine model
    .


    Figure 1 Using random forest to predict the top 10 variables of thyroid-related adverse events in cancer patients treated with ICIS (estimated by importance)

    Figure 1 Using random forest to predict the top 10 variables of thyroid-related adverse events in cancer patients treated with ICIS (estimated by importance)

    Figure 2 Receiver operating characteristic curves for the prediction performance of Elastic Network (ENET), Logistic Regression (LR), Random Forest (RF) and Support Vector Machine Radial (SVM_R)

    Figure 2 Receiver operating characteristic curves for the prediction performance of Elastic Network (ENET), Logistic Regression (LR), Random Forest (RF) and Support Vector Machine Radial (SVM_R)

    Table 3 Details of the machine learning model
    .

    Table 3 Details of the machine learning model
    .


    Conclusion: This study used a variety of machine learning models to predict and found that factors such as smoking history, hypertension, and opioids were associated with thyroid-related adverse events in cancer patients receiving PD-1/PD-L1 inhibitors
    .

    This study used a variety of machine learning models to predict and found that factors such as smoking history, hypertension, and opioids were associated with thyroid-related adverse events in cancer patients receiving PD-1/PD-L1 inhibitors
    .


    Original source:

    Kim W, Cho YA, Kim DC,et al.


    Factors Associated with Thyroid-Related Adverse Events in Patients Receiving PD-1 or PD-L1 Inhibitors Using Machine Learning Models in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.